Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medvance was a prominent international clinical research organization (CRO) and consultancy specializing in medical affairs, clinical development, and pharmacovigilance. Founded in 1997 and headquartered in the United Kingdom, the company provided specialized services to the pharmaceutical and biotechnology industries, with a strong focus on the European market. Medvance was particularly recognized for its expertise in late-phase clinical trials, medical communications, and regulatory affairs. In 2011, the company was acquired by INC Research (which later merged with inVentiv Health to form Syneos Health), a move that significantly expanded INC's medical affairs capabilities and European footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medvance.